Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-09625 · Session 1

Whether the drug Trastu'umab (Herceptin) will be made available to health boards for the treatment of metastatic breast cancer.

Answered Asked by Dorothy-Grace Elder SNP Lodged 5 Sep 2000

The question

To ask the Scottish Executive whether the drug Trastu'umab (Herceptin) will be made available to health boards for the treatment of metastatic breast cancer.

The answer

Answered by Susan Deacon on 15 Nov 2000 · 71 days after it was lodged, 57 days after it was due

The treatment of patients with breast cancer is a matter for specialists experienced in the management of cancer and the question of whether individual patients might benefit from treatment with Trastuzumab (Herceptin) is a matter for the clinical judgement of the specialist concerned.

In the Official Report

No contribution in the Official Report cites S1W-09625 by reference.